China Coronary Microvascular Disease(CCMD) Registry

Henan Institute of Cardiovascular Epidemiology1 site in 1 country500 target enrollmentNovember 11, 2024

ConditionsCoronary Microvascular Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronary Microvascular Disease
Sponsor: Henan Institute of Cardiovascular Epidemiology
Enrollment: 500
Locations: 1
Primary Endpoint: Establish a Registry of CMD patients in China
Status: Recruiting
Last Updated: 8 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.

Registry

clinicaltrials.gov

Start Date

November 11, 2024

End Date

October 10, 2029

Last Updated

8 months ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Henan Institute of Cardiovascular Epidemiology

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Angina symptoms
•Objective evidence of myocardial ischemia
•Coronary angiography was normal,irregular tube wall, or stenosis \<50%

Exclusion Criteria

•People under the age of 18
•Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease